Willa D Brenowitz1,2, Adina Zeki Al Hazzouri3, Eric Vittinghoff2, Sherita H Golden4, Annette L Fitzpatrick5, Kristine Yaffe1,2,6,7. 1. Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, CA, USA. 2. Department of Epidemiology and Biostatistics, University of California San Francisco, CA, USA. 3. Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, USA. 4. Department of Medicine Johns Hopkins University School of Medicine and Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 5. Departments of Family Medicine, Epidemiology, and Global Health, School of Public Health, University of Washington, WA, USA. 6. Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, CA, USA. 7. San Francisco VA Health Care System, San Francisco, CA, USA.
Abstract
BACKGROUND: Depressive symptoms may increase risk for dementia, but findings are controversial because late-life depression may be a prodromal dementia symptom. Life course data on depression and dementia risk may clarify this association; however, data is limited. OBJECTIVE: To impute adult depressive symptoms trajectories across adult life stages and estimate the association with cognitive impairment and decline. METHODS: Using a pooled study of 4 prospective cohorts (ages 20-89), we imputed adult life course depressive symptoms trajectories based on Center for Epidemiologic Studies Depression Scale-10 (CESD-10) and calculated time-weighted averages for early adulthood (ages 20-49), mid-life (ages 50-69), and late-life (ages 70-89) for 6,122 older participants. Adjusted pooled logistic and mixed-effects models estimated associations of imputed depressive symptoms with two cognitive outcomes: cognitive impairment defined by established criteria and a composite cognitive score. RESULTS: In separate models, elevated depressive symptoms in each life stage were associated with cognitive outcomes: early adulthood OR for cognitive impairment = 1.59 (95%CI: 1.35,1.87); mid-life OR = 1.94 (95%CI:1.16, 3.26); and late-life OR = 1.77 (95%CI:1.42, 2.21). When adjusted for depressive symptoms in the other life-stages, elevated depressive symptoms in early adulthood (OR = 1.73; 95%CI: 1.42,2.11) and late-life (OR = 1.43; 95%CI: 1.08,1.89) remained associated with cognitive impairment and were also associated with faster rates of cognitive decline (p < 0.05). CONCLUSION: Imputing depressive symptom trajectories from pooled cohorts may help expand data across the life course. Our findings suggest early adulthood depressive symptoms may be a risk factor for cognitive impairment independent of mid- or late-life depressive symptoms.
BACKGROUND: Depressive symptoms may increase risk for dementia, but findings are controversial because late-life depression may be a prodromal dementia symptom. Life course data on depression and dementia risk may clarify this association; however, data is limited. OBJECTIVE: To impute adult depressive symptoms trajectories across adult life stages and estimate the association with cognitive impairment and decline. METHODS: Using a pooled study of 4 prospective cohorts (ages 20-89), we imputed adult life course depressive symptoms trajectories based on Center for Epidemiologic Studies Depression Scale-10 (CESD-10) and calculated time-weighted averages for early adulthood (ages 20-49), mid-life (ages 50-69), and late-life (ages 70-89) for 6,122 older participants. Adjusted pooled logistic and mixed-effects models estimated associations of imputed depressive symptoms with two cognitive outcomes: cognitive impairment defined by established criteria and a composite cognitive score. RESULTS: In separate models, elevated depressive symptoms in each life stage were associated with cognitive outcomes: early adulthood OR for cognitive impairment = 1.59 (95%CI: 1.35,1.87); mid-life OR = 1.94 (95%CI:1.16, 3.26); and late-life OR = 1.77 (95%CI:1.42, 2.21). When adjusted for depressive symptoms in the other life-stages, elevated depressive symptoms in early adulthood (OR = 1.73; 95%CI: 1.42,2.11) and late-life (OR = 1.43; 95%CI: 1.08,1.89) remained associated with cognitive impairment and were also associated with faster rates of cognitive decline (p < 0.05). CONCLUSION: Imputing depressive symptom trajectories from pooled cohorts may help expand data across the life course. Our findings suggest early adulthood depressive symptoms may be a risk factor for cognitive impairment independent of mid- or late-life depressive symptoms.
Entities:
Keywords:
Cognitive impairment; dementia; depression; imputation; life course
Authors: Allen T C Lee; Ada W T Fung; Marcus Richards; Wai C Chan; Helen F K Chiu; Ruby S Y Lee; Linda C W Lam Journal: J Affect Disord Date: 2020-12-30 Impact factor: 4.839
Authors: Adina Zeki Al Hazzouri; Eric Vittinghoff; Amy Byers; Ken Covinsky; Dan Blazer; Susan Diem; Kristine E Ensrud; Kristine Yaffe Journal: J Gerontol A Biol Sci Med Sci Date: 2013-10-04 Impact factor: 6.053
Authors: Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky Journal: JAMA Date: 2002-09-25 Impact factor: 56.272
Authors: Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Deborah E Barnes; Kristine Yaffe; Amy L Byers; Mark McCormick; Catherine Schaefer; Rachel A Whitmer Journal: Arch Gen Psychiatry Date: 2012-05
Authors: Nan Huo; Prashanthi Vemuri; Jonathan Graff-Radford; Jeremy Syrjanen; Mary Machulda; David S Knopman; Clifford R Jack; Ronald Petersen; Michelle M Mielke Journal: Neurology Date: 2022-01-05 Impact factor: 9.910
Authors: Ganesh M Babulal; Yiqi Zhu; Catherine M Roe; Darrell L Hudson; Monique M Williams; Samantha A Murphy; Jason Doherty; Ann M Johnson; Jean-Francois Trani Journal: Alzheimers Dement Date: 2022-02-25 Impact factor: 16.655